Ingrid Alfheim

Bio-Medisinsk Innovasjon AS engages in the development of biotechnology, bio-medical and pharmaceutical businesses. The firm acts as an investor and incubator for start-ups. The company was founded in 2004 and is headquartered in Oslo, Norway.

siRNAsense AS focuses on developing pipeline drugs. Its sources projects include Biotechnology Centre of Oslo, Centre for Molecular Biology and Neuroscience, Rikshospitalet-Radiumhospitalet HF and University of Oslo. The company was founded in December 2004 and is headquartered in Oslo, Norway.

Serodus ASA is a bio-medical company, which engages in the development of medicines for the treatment of diabetes related complications. It focuses on diabetic kidney disease, diabetic retinopathy, type 1 diabetes, and diabetic foot ulcers. The company was founded by Finn Olav Levy on January 21, 2008 and is headquartered in Oslo, Norway.

Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway.

Part of Abbott Laboratories, Axis Shield PoC AS is a Norwegian company that manufactures diagnostic testing devices. The company is based in Oslo, Norway. Kjersti Grimsrud has been the CEO of the company since 1987.